Cancer Genetics, Inc. (CGIX): Price and Financial Metrics
CGIX Price/Volume Stats
| Current price | $4.61 | 52-week high | $17.50 |
| Prev. close | $4.72 | 52-week low | $2.11 |
| Day low | $4.30 | Volume | 612,400 |
| Day high | $4.69 | Avg. volume | 2,437,482 |
| 50-day MA | $5.46 | Dividend yield | N/A |
| 200-day MA | $3.87 | Market Cap | 18.83M |
CGIX Stock Price Chart Interactive Chart >
Cancer Genetics, Inc. (CGIX) Company Bio
Cancer Genetics, Inc. develops, commercializes, and provides molecular and biomarker-based tests and services in the United States, India, and China. Its tests enable physicians to personalize the clinical management of each individual patient by providing genomic information to diagnose, monitor, and inform cancer treatment; and enable biopharmaceutical companies involved in oncology trials to select candidate populations and reduce adverse drug reactions by providing information regarding genomic factors influencing subject responses to therapeutics. The company was founded in 1999 and is based in Rutherford, New Jersey.
CGIX Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | -10.83% |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | 0.00% |
| 2020 | -53.52% |
| 2019 | -17.22% |
Continue Researching CGIX
Want to see what other sources are saying about Cancer Genetics Inc's financials and stock price? Try the links below:Cancer Genetics Inc (CGIX) Stock Price | Nasdaq
Cancer Genetics Inc (CGIX) Stock Quote, History and News - Yahoo Finance
Cancer Genetics Inc (CGIX) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...